Clinical trial · Interventional
DART: Diagnostic-CT-Enabled Planning: A Randomized Trial in Palliative Radiation Therapy
NCT05233904CI-TRIAL-00059048DARTunknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The objective of this trial is to assess the efficacy, acceptability, and scalability of diagnostic-CT-enabled planning, compared to conventional CT simulation planning.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Advanced Cancer Requiring Palliative Radiation | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Diagnostic-CT-enabled Planning | Diagnostic Test | — | UNRESOLVED |
| Standard of Care | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- Standard of Care
- description
- Patients will be booked for CT simulation and treatment as per the local institution's standard practice.
- interventionNames
- Diagnostic Test: Standard of Care
- type
- EXPERIMENTAL
- label
- Experimental Treatment Workflow
- description
- Patients do not require a CT simulation appointment. A radiation treatment appointment will be scheduled on an optical surface guidance-equipped treatment unit as soon as available, but a minimum of 24 hours is required between EBAF processing and fraction 1.
- interventionNames
- Diagnostic Test: Diagnostic-CT-enabled Planning
Primary outcomes (1)
- measure
- Time in Centre (TIC) on Treatment Day
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Age 18 years or older * Able to provide informed consent * Patient has consented to PRT to bone/soft tissue metastases or primary targets in the thorax, abdomen, or pelvis and RO will use simple planning techniques (i.e. parallel-opposed pair or direct field beam arrangement) * Patient will be scheduled for same-day simulation and treatment (if randomized to Arm 1) * Patient has a pre-existing and recent (i.e. within 4 weeks of time of enrollment) diagnostic CT or CT-fused scan with full visualization of the region-of-interest which has been acquired from an approved diagnostic scanner * Patient positioning scan is deemed acceptable and reproducible (e.g., patient is lying supine and relatively flat, there is no/minimal motion blur, ect.) * Intravenous (IV)/oral contrast in the region-of-interest is permitted as long as it does not create artifact which obscured the target volume (density override calculations may be required) Exclusion Criteria: * Any contraindication to receiving radiation * Oncologic emergencies and/or on-call cases * Pregnant or lactating women * Cases requiring composite dosimetric planning to account for previous radiotherapy or extended distance set-up
References
Publications (1)
- DERIVEDO'Neil M, Nguyen TK, Laba J, Dinniwell R, Warner A, Palma DA. DART: diagnostic-CT-enabled planning: a randomized trial in palliative radiation therapy (study protocol). BMC Palliat Care. 2022 Dec 9;21(1):220. doi: 10.1186/s12904-022-01115-y. PMID 36482335